← Research Library
Chronic Pain1 min read

Therapeutic and Diagnostic Landscape of Diabetic Neuropathy: A Systematic Review of Clinical Studies.

Cureus·February 2026·Jay Prakash S Rajput, Rahul Deb, Sajidali S Saiyad et al.
Share:PostShare

Key Finding

Pharmacological agents including pregabalin, duloxetine, and α-lipoic acid demonstrated the most consistent efficacy for diabetic neuropathy, with complementary therapies like acupuncture showing preliminary promise requiring further validation.

What This Means For You

Diabetic neuropathy is nerve damage that affects up to half of people with diabetes, causing pain, numbness, and balance problems that can lead to foot ulcers and reduced quality of life. Researchers recently reviewed 76 clinical studies published between 2020 and 2025 to understand which treatments work best for diagnosing and managing this condition. The review found that prescription medications like pregabalin and duloxetine were most effective for pain relief, while spinal cord stimulation helped patients who didn't respond to other treatments. Exercise programs improved walking ability and balance, and advanced wound dressings helped heal foot ulcers faster. Importantly, the review identified acupuncture as a complementary therapy showing preliminary promise for diabetic neuropathy symptoms. While acupuncture appears beneficial based on initial evidence, the researchers noted that more rigorous studies are needed to confirm its effectiveness and understand exactly how it helps. For patients with diabetic neuropathy, this research suggests that combining different treatment approaches—including medications, physical therapy, and potentially acupuncture—may offer the best outcomes. The study highlights that managing diabetic neuropathy requires a comprehensive approach tailored to each person's specific symptoms, whether that's pain, balance issues, or foot complications. If you're considering acupuncture for diabetic neuropathy, consult with a licensed acupuncturist experienced in treating diabetes-related complications.

Clinical Notes for Practitioners

This systematic review synthesized 76 clinical studies (2020-2025) examining diagnostic and therapeutic strategies for diabetic neuropathy, following PRISMA guidelines with data from PubMed, EMBASE, CENTRAL, and Web of Science. Pharmacological interventions—pregabalin, duloxetine, and α-lipoic acid—demonstrated the most consistent efficacy, with significant pain reduction and improved nerve conduction velocity. High-frequency spinal cord stimulation provided sustained pain relief in refractory cases, while exercise-based rehabilitation improved gait velocity and balance parameters. Advanced wound care including platelet-rich plasma dressings and bioengineered skin substitutes accelerated ulcer healing. Acupuncture and balneotherapy were identified as complementary therapies showing preliminary promise but requiring further validation through robust trials. Nerve conduction studies combined with validated scoring instruments remain gold-standard diagnostics, with emerging biomarker and microvascular assessment techniques as adjuncts. Clinical takeaway: Multimodal integration of pharmacological, device-based, and rehabilitative approaches optimizes outcomes, though evidence gaps persist for small-fiber and autonomic neuropathies, warranting controlled research.

Found this research helpful?

Share:PostShare
🌿

Ready to try acupuncture for Chronic Pain?

Browse our directory of verified licensed practitioners near you.

Find a practitioner →

Related researchin Chronic Pain